Work

Feasibility and safety results from RAD-IO: A multi-stage trial of durvalumab with chemoradiotherapy with 5-fluorouracil and mitomycin C in patients with muscle-invasive bladder cancer.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.4504

Authors: Nicholas David James, Joseph van de Wiel, Maria De Santis, Omar Sadeeq Din, Daniel Ford, Shaista Hafeez, Robert A. Huddart, Ana Hughes, James Iddenden, Romaana Mir, Catalina Vassallo - Bonner, Anjali Zarkar, Sarah Pirrie, Syed A. Hussain

Institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Royal Marsden Hospital, University of Birmingham, Medical University of Vienna, Charité - Universitätsmedizin Berlin, Weston Park Cancer Centre, Queen Elizabeth Hospital Birmingham, Clatterbridge Cancer Centre NHS Foundation Trust, Mount Vernon Cancer Centre, University of Sheffield

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca UK

OpenAlex ID: W7162546599

Cites:

Cited by: 2

Related to: